On June 10, 2019, the North Carolina Division of Public Health was notified by the Buncombe County Health Department of three cases of Lyme disease among children aged 6--8 years. Lyme disease is a bacterial infection transmitted by the bite of an *Ixodes scapularis* tick that is infected most commonly with the bacterium *Borrelia burgdorferi*. An investigation conducted by Buncombe County communicable disease nurses determined that all three children were homeschooled and had attended a local, year-round, outdoor wilderness day camp. Each child had attended the camp at least 1 day a week over the course of the previous fall and spring. The camp site for the wilderness program is completely outdoors, with a canopy of hardwood forest providing much of the shelter. Further investigation identified an earlier camp participant who had received a diagnosis of Lyme disease in 2017 ([Table](#T1){ref-type="table"}).

###### Demographic information and clinical and laboratory evidence of Lyme disease in four attendees at a wilderness day camp --- North Carolina, 2017 and 2019

  Patient                               Age (yrs)                                    Sex             Date of illness onset   Clinical evidence                            Laboratory evidence                                Tick exposure                  Treatment     Case classification
  ------------------------------------- -------------------------------------------- --------------- ----------------------- -------------------------------------------- -------------------------------------------------- ------------------------------ ------------- ---------------------
  **A**                                 8                                            Female          May 12, 2019            Brief, recurrent attacks of joint swelling   Positive *Borrelia burgdorferi* IgG western blot   Attended wilderness day camp   Doxycycline   Confirmed
  Arthralgia                            Positive *B. burgdorferi* IgM western blot   Ticks removed                                                                                                                                                                        
  Physician diagnosis of Lyme disease                                                                                                                                                                                                                                     
  **B**                                 6                                            Female          May 1, 2019             Erythema migrans rash                        Negative *B. burgdorferi* IgG western blot         Attended wilderness day camp   Doxycycline   Confirmed
  Fever                                 Positive *B. burgdorferi* IgM western blot   Ticks removed                                                                                                                                                                        
  Headaches                             Positive Lyme disease antibody EIA, 1.77                                                                                                                                                                                          
  Arthralgia                                                                                                                                                                                                                                                              
  Loss of appetite                                                                                                                                                                                                                                                        
  Increased fatigue                                                                                                                                                                                                                                                       
  Physician diagnosis of Lyme disease                                                                                                                                                                                                                                     
  **C**                                 7                                            Male            May 17, 2019            Small erythematous rash                      Negative *B. burgdorferi* IgG western blot         Attended wilderness day camp   Doxycycline   Probable\*
  Fever                                 Positive *B. burgdorferi* IgM western blot   Ticks removed                                                                                                                                                                        
  Headaches                             Positive Lyme disease antibody EIA, 3.26                                                                                                                                                                                          
  Physician diagnosis of Lyme disease                                                                                                                                                                                                                                     
  **D**                                 9                                            Male            September 28, 2017      Erythema migrans rash                        Positive *B. burgdorferi* IgG western blot         Attended wilderness day camp   Doxycycline   Confirmed
  Radiculoneuropathy                    Positive *B. burgdorferi* IgM western blot                                                                                                                                                                                        
  Cranial neuritis (Bell's palsy)       Positive Lyme disease antibody EIA, 11.08                                                                                                                                                                                         
  Arthralgia                                                                                                                                                                                                                                                              
  Physician diagnosis of Lyme disease                                                                                                                                                                                                                                     

**Abbreviations:** EIA = enzyme immunoassay; Ig = immunoglobulin.

\* <https://wwwn.cdc.gov/nndss/conditions/lyme-disease/case-definition/2017/>.

North Carolina has historically had a low incidence of reported Lyme disease cases ([@R1]) but remains the southernmost border of the leading edge of Lyme disease in the United States ([@R2]). In North Carolina in 2017, 0.69 confirmed cases of Lyme disease per 100,000 residents were reported, a rate significantly lower than the 2017 national average of 9.1 confirmed cases per 100,000 residents ([@R3]).

On June 13, a North Carolina interagency assessment team traveled to the wilderness day camp to conduct entomologic surveillance for *Ixodes* ticks. Participants covered a total of 0.27 acres (1,077 m^2^) of land while "flagging and dragging."[\*](#FN1){ref-type="fn"} A total of 39 nymphal ticks were collected. Ticks were preserved in 95% ethanol and sent to CDC's Division of Vector-Borne Diseases in Fort Collins, Colorado, for pathogen testing. Of the 39 ticks collected, 37 (95%) were confirmed as *Ixodes scapularis* ticks by molecular testing. Two ticks yielded poor DNA, and pathogen tests were ruled inconclusive. Six of the 35 ticks yielding DNA suitable for analysis tested positive for *B. burgdorferi* sensu stricto, the causative agent of Lyme disease. One of the six ticks was coinfected with *Borrelia miyamotoi*. All 35 ticks tested negative for *Anaplamsa phagocytophilum* and *Babesia microti* (two pathogens tested for when conducting *Ixodes* tick testing). Results indicated that nymphal ticks collected at the camp site had a *B. burgdorferi* infection prevalence of 17% (95% confidence interval = 8.1--32.7).

This was the first reported cluster of Lyme disease patients with a common exposure to be identified in North Carolina and the furthest south that *Borrelia*-infected ticks have been identified through North Carolina Division of Public Health entomologic surveillance efforts. Clinicians should be aware of the risk for transmission of Lyme disease in North Carolina and consider recommended diagnostic testing and treatment ([@R4]). To prevent exposure to *Borrelia* and other tickborne diseases, North Carolina Division of Public Health encourages everyone to wear personal protective clothing, to use EPA-approved repellents such as diethyltoluamide (DEET), and to conduct full-body examinations for ticks following outdoor activities in possible tick habitats. Prevention is the best defense against Lyme disease. Close collaboration between the North Carolina Division of Public Health and county health departments, along with clinician awareness, are essential for rapid identification of vector-borne disease expansion and appropriate treatment.

To sample the environment for ticks trying to locate a host, light-colored cloths with a wooden leading frame are dragged through grass or a leafy forest floor (dragging), and light colored cloths are used to brush uneven surfaces such as small bushes in wooded areas (flagging).
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